Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Uterine Cancer

Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas

Online download statistics by month:

Online download statistics by month: January 2019 to January 2021

	Abstract	Full	Pdf
Jan 2019	40	0	0
Feb 2019	222	0	0
Mar 2019	174	0	0
Apr 2019	106	0	0
May 2019	52	0	1
Jun 2019	46	0	1
Jul 2019	68	0	1
Aug 2019	115	0	2
Sep 2019	104	0	1
Oct 2019	37	0	1
Nov 2019	33	0	0
Dec 2019	52	0	2
Jan 2020	49	0	0
Feb 2020	34	0	0
Mar 2020	26	0	1
Apr 2020	284	0	0
May 2020	148	0	3
Jun 2020	432	0	1
Jul 2020	458	0	0
Aug 2020	261	0	0
Sep 2020	160	0	0
Oct 2020	15	0	0
Nov 2020	15	0	0
Dec 2020	12	0	0
Jan 2021	8	0	2
Total	2951	0	16